Compare Biogen Inc (BIIB) vs Cadence Design Systems Inc (CDNS) Price & Performance

Biogen IncTrade

Cadence Design Systems IncTrade

Price performance (Past 24H)

Key statistics

Biogen Inc vs Cadence Design Systems Inc — how do they compare? Biogen Inc trades at $191.5 (market cap $30.86B), while Cadence Design Systems Inc trades at $376.8 (market cap $104.24B). The key difference: Cadence Design Systems Inc is far larger — about 3.4× Biogen Inc's market cap. Which is the better fit depends on your goals.

	BIIB	CDNS
Market Cap	$30.86B	$104.24B
Sector	Health	Technology
52-Week High	$216.63	$416.39
52-Week Low	$122.68	$265.66
Enterprise Value	$33.14B	$105.91B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BIIB

Real-world study shows 83% of early Alzheimer's patients stable or improved on LEQEMBI over 17 monthsPRNewsWire · 20 hours agoBullish Biogen's diranersen shows promising Phase 2 results slowing early Alzheimer's decline and reducing tau protein.GlobeNewsWire · 22 hours agoBullish FDA approves LEQEMBI IQLIK, first at-home weekly injection for early Alzheimer's treatmentPRNewsWire · 1 day agoBullish View details →

CDNS

Global silicon interposer market to reach $14B by 2035, driven by AI and advanced chip tech growth.Sns Insider · 4 days agoBullish View details →

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

About Cadence Design Systems Inc

Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.